[Clinical features of patients with malignant peritoneal mesothelioma initially presenting as a local inflammation]

Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):312-3.
[Article in Chinese]
No abstract available

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Calbindin 2 / metabolism
  • Cholecystitis / pathology
  • Cisplatin / administration & dosage
  • Cystitis / pathology
  • Diagnosis, Differential
  • Female
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Humans
  • Inflammation / pathology*
  • Keratins / metabolism
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Male
  • Mesothelioma / drug therapy
  • Mesothelioma / metabolism
  • Mesothelioma / pathology*
  • Mesothelioma / surgery
  • Mesothelioma, Malignant
  • Middle Aged
  • Pemetrexed
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / metabolism
  • Peritoneal Neoplasms / pathology*
  • Peritoneal Neoplasms / surgery
  • Survival Rate
  • Vimentin / metabolism

Substances

  • Calbindin 2
  • Glutamates
  • Vimentin
  • Pemetrexed
  • Guanine
  • Keratins
  • Cisplatin